omeprazole sulfone has been researched along with thiabendazole in 1 studies
| Studies (omeprazole sulfone) | Trials (omeprazole sulfone) | Recent Studies (post-2010) (omeprazole sulfone) | Studies (thiabendazole) | Trials (thiabendazole) | Recent Studies (post-2010) (thiabendazole) |
|---|---|---|---|---|---|
| 50 | 12 | 17 | 1,939 | 44 | 213 |
| Protein | Taxonomy | omeprazole sulfone (IC50) | thiabendazole (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.8 | |
| Methionine aminopeptidase | Escherichia coli K-12 | 0.472 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.472 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afzelius, L; Andersson, TB; Baroni, M; Cruciani, G; Karlén, A; Masimirembwa, CM; Mecucci, S; Zamora, I | 1 |
1 other study(ies) available for omeprazole sulfone and thiabendazole
| Article | Year |
|---|---|
Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.
Topics: Amino Acids; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P-450 CYP2C9; Enzyme Inhibitors; Models, Molecular; Molecular Conformation; Molecular Structure; Quantitative Structure-Activity Relationship | 2004 |